| 埃博拉病毒疫苗rVSV-ZEBOV的研究进展 |
| |
| 引用本文： | 张杨玲,汪园,张革. 埃博拉病毒疫苗rVSV-ZEBOV的研究进展[J]. 中国生物工程杂志, 2018, 38(1): 51-56. DOI: 10.13523/j.cb.20180106 |
| |
| 作者姓名： | 张杨玲 汪园 张革 |
| |
| 作者单位： | 中山大学药学院 广州 510006 |
| |
| 摘 要： | 埃博拉病毒被列为A类病原体,感染后可引起埃博拉出血热,具有高传染率和高致死率。研发安全有效的抗病毒疫苗迫在眉睫。目前正在研发的埃博拉病毒疫苗包括病毒载体疫苗、蛋白疫苗、DNA疫苗等,其中最有希望的是重组水疱性口炎病毒载体疫苗rVSV-ZEBOV。该疫苗在预防和治疗埃博拉出血热方面具有较高的安全性和有效性,有望在2018年上市。为了深入了解rVSV-ZEBOV疫苗,现主要从制备方法、药理学研究和作用机制等方面对该疫苗进行介绍。
|
| 关 键 词： | 埃博拉病毒 rVSV-ZEBOV疫苗 制备方法 药理学研究 作用机制 |
| 收稿时间： | 2017-07-21 |
Advances in Research on Ebola Virus Vaccine: rVSV-ZEBOV |
| |
| Yang-ling ZHANG,Yuan WANG,Ge ZHANG. Advances in Research on Ebola Virus Vaccine: rVSV-ZEBOV[J]. China Biotechnology, 2018, 38(1): 51-56. DOI: 10.13523/j.cb.20180106 |
| |
| Authors: | Yang-ling ZHANG Yuan WANG Ge ZHANG |
| |
| Abstract: | Ebola viruses are the causative agents of Ebola hemorrhagic fever with high infection rates and high fatality rates, which were classified as category A pathogens. A safe and effective vaccine against Ebola virus infection is urgently needed. Currently, the Ebola virus vaccine candidates under study include viral vectors vaccines, protein vaccines and DNA vaccines. Among them, the most promising vaccine candidate is the recombinant vesicular stomatitis viral vector-based vaccine: rVSV-ZEBOV. The vaccine is safe and effective in prevention and treatment Ebola hemorrhagic fever. It is expected to be available in 2018. In order to gain an in-depth understanding of rVSV-ZEBOV vaccine, the preparation, pharmacological studies, and mechanism of action of rVSV-ZEBOV vaccine are focused on. |
| |
| Keywords: | Ebola virus rVSV-ZEBOV Preparation Pharmacological studies Mechanism |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中国生物工程杂志》浏览原始摘要信息 |
|
点击此处可从《中国生物工程杂志》下载全文 |
|
